Speaking of Mol Bio

Multi-omics is a great example of how the scientific community is thinking larger and using complementary methods to gather deeper information to understand biology and inform medicine.  Proteomics is just one of the -omes of multi-omics but it’s the one that Steve Williams, Chief Medical Officer at SomaLogic, has over 30 years’ experience in. Steve joins us to share his story and insights on how...

In this episode, we talk with Chris Whelan about the data behind science.  Chris is the Director of Neuroscience, Data Science & Digital Health for Research and Development at The Janssen Pharmaceutical Companies of Johnson & Johnson, as well as the Chair of the UK Biobank Pharma Proteomics project. He connects the dots between genomics and proteomics and clarifies how omics can be used to underst...

Since it’s discovery, CRISPR Cas9 gene editing technology has blossomed and boomed.  It’s moved from a highly technical niche technique to one that is arguably mainstream and being applied to countless challenges in applied biology. In this episode we talk with Travis Hardcastle, who previously worked in R&D to develop gene editing products and is now a Product Manager for Engineered Cell Lines at...

Experience the Speaking of Mol Bio podcast in its extended video format for a more immersive journey, while also ensuring accessibility with downloadable transcripts for each episode. Watch now at thermofisher.com/podcast-video A short trailer to introduce the Speaking of Mol Bio co-hosts and get their take on what the series is all about.  You'll hear about the four topics covered in this first s...